Epitalon Dose Protocol: Typical Schedules, Research Context, and Safety

A common epitalon dose protocol in research and online community discussions uses 5–10 mg per day for 10–20 days, often repeated once or twice per year. Epitalon is not FDA-approved for human use in the United States, and no standard medical dose exists. The details below summarize published research, typical community schedules, and safety considerations rather than prescribing a protocol.

What Is Epitalon?

Epitalon (also spelled Epithalon) is a synthetic tetrapeptide with the amino acid sequence Ala-Glu-Asp-Gly. It was developed by Russian researcher Vladimir Khavinson and studied for effects on telomerase activity and the pineal gland. Most human data comes from small, older studies rather than modern randomized controlled trials.

Epitalon is sometimes confused with epithalamin, a pineal extract, but they are not the same product. Because epitalon is not a prescription drug in the US, it is typically sold as a research chemical. That means purity, sterility, and actual content can vary widely between vendors.

Typical Epitalon Dose Protocols Discussed in Research

The most frequently cited schedules come from translated Russian studies and later community reports. Daily amounts usually fall between 5 mg and 10 mg, given for 10 to 20 consecutive days. Some translated papers describe 10 mg daily for 10 days, while others use 5 mg daily for 20 days. A second cycle is sometimes used 4–6 months later.

Protocol label	Daily dose	Cycle length	Route	Notes
Low-dose research	5 mg	10–20 days	Subcutaneous	Often discussed by first-time researchers
Standard research	10 mg	10–20 days	Subcutaneous	Most cited in translated papers
Intranasal	5–10 mg	10–20 days	Intranasal	Absorption may be less consistent
Extended cycle	5 mg	20 days	Subcutaneous	Sometimes repeated twice yearly

No head-to-head study has proven that one epitalon dose protocol is superior to another. The 10 mg daily for 10–20 days schedule appears most often in discussion, but it is not an FDA-approved regimen.

Subcutaneous vs Intranasal Epitalon Dosing

Subcutaneous injection

Most research protocols use once-daily subcutaneous injection. Common injection sites include the abdomen and thigh. Sterile technique, proper needle disposal, and cold storage are essential to reduce infection risk.

Intranasal spray

Some vendors sell epitalon as an intranasal spray. Absorption through the nasal mucosa may be lower and more variable than injection. No published human trial has directly compared intranasal and subcutaneous epitalon at the same dose.

Route	Typical daily amount	Consistency	Common in research?
Subcutaneous	5–10 mg	Higher and more predictable	Yes
Intranasal	5–10 mg	Lower and more variable	Less common

Cycle Length, Timing, and Realistic Expectations

Epitalon cycles are usually short: 10 to 20 days, followed by a break of several months. Continuous daily use is not typical in the research literature. Some users dose in the evening to mimic natural pineal rhythms, but this timing has not been confirmed in clinical trials.

Most users report taking at least 3–6 months off between cycles to avoid continuous exposure. Anecdotal reports and epitalon before and after pictures are widely shared online. These images do not prove that epitalon works, and they should never be used to judge safety or effectiveness.

Safety, Legal Status, and Medical Guidance

Epitalon is not FDA-approved for human use in the United States. It is sold as a research chemical, not as a prescription drug or dietary supplement. That means no government agency has verified its purity, dosage, or safety for people.

No peer-reviewed human trial has established a standard epitalon dose protocol. Reported side effects in small studies have generally been mild, but long-term safety data is lacking. Anyone considering epitalon should consult a licensed healthcare professional first.

Legal status can also vary by state and by vendor. Buying peptides from unregulated sources carries risks, including contamination, incorrect labeling, and injection-site infections. Purity testing through a third-party lab is often recommended in research communities, but it does not make an unapproved peptide safe for human use.

Related Peptide Protocols People Compare

People researching epitalon often compare it with other peptides that have different goals and dosing logic. For example, those interested in fat loss may review the aod 9604 dosage protocol, while people focused on growth hormone release often look at the cjc-1295 ipamorelin protocol.

Mitochondrial health discussions sometimes mention the ss-31 and mots-c protocol. Some community write-ups describe the anela protocol epitalon as an alternative schedule, but that is not a recognized medical standard. Always treat online protocols as unverified information, not as clinical guidance.

In short, the most common epitalon dose protocol is 5–10 mg per day for 10–20 days, but no FDA-approved dose exists. Anyone considering it should prioritize safety, legal status, and professional medical advice over forum posts or before-and-after photos.

COMMON QUESTIONS

Frequently Asked Questions

What is the typical epitalon dose protocol?

Most discussed epitalon protocols use 5–10 mg per day for 10–20 days, often repeated once or twice per year. No FDA-approved human dose exists, and these numbers come from small studies and community reports, not from controlled clinical trials.

How is epitalon administered?

Epitalon is usually administered by subcutaneous injection once daily in research settings. Intranasal sprays are also sold, but absorption is likely less consistent. Neither route is FDA-approved for human use.

Is epitalon safe and legal in the US?

Epitalon is not FDA-approved for human use and is typically sold as a research chemical. Long-term safety data is lacking, and legal status can vary by state. Consult a licensed healthcare professional before considering any peptide.